CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted
Drug / intervention
Insulindrug
Likely dose
Insulin 180mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00984737
NCT00984737N/ACompleted
CompareCT.gov

Newly Diagnosed Hyperglycemia and Stress Hyperglycemia in a Coronary Intensive Care Unit

Baskent University·interventional·Posted Sep 25, 2009·Updated Sep 25, 2009

In Brief

A clinical study evaluating Insulin for Diabetes Mellitus and 3 related conditions. Completed, across 1 site.

Detailed Summary

Newly diagnosed hyperglycemia (NDH) and stress hyperglycemia (SH) during acute illness is reported as a non-physiological condition in hospitals. The investigators aim is to determine the rate of NDH and SH among cases admitted to coronary ICU with acute coronary disease and to inquire the relationship of SH with disease severity and functional outcomes such as longevity of ICU stay.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes Mellitus, Hyperglycemia, Blood Glucose, Myocardial Ischemia
CountriesTurkey (Türkiye)
Collaborators--

Timeline

N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 25, 2009
Enrollment StartMay 1, 2007
Primary CompletionNov 1, 2008
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 16.8 years ago

Interventions

Insulindrug

Capillary glucose measurements of Group 2 and Group 3 will be performed during hospitalization and will be treated when they are over 180mg/dl. Short acting oral anti-diabetic drugs will be given to patients who refuse insulin injection.